Clinical Trials Logo

Clinical Trial Summary

This is a randomized trial comparing progesterone with conventional clobetasol propionate in patients with vulvar lichen sclerosus.


Clinical Trial Description

Background A total of 62 female patients with first diagnosis of lichen sclerosus will be treated daily with either topical progesterone 8% or clobetasol propionate 0.05% for 12 weeks. Response to the treatment will be evaluated by macroscopic description of the dermatologic phenotype by using a specific lichen sclerosus score and photography-documentation. The symptoms and quality of life of the patients will be evaluated by standardized questionnaires. Additionally, tissue samples will be taken before and again after 12 weeks of treatment to evaluate the response status. Objective The purpose of this study is to compare progesterone with conventional clobetasol propionate in a superiority trial. Methods Prospective, randomized, controlled, superiority phase II pilot trial. Patients will be randomized 1:1 to either progesterone or clobetasol propionate, with patients, physicians, assessors and analysts being blinded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01126255
Study type Interventional
Source University Hospital Inselspital, Berne
Contact
Status Terminated
Phase Phase 2
Start date March 2011
Completion date July 2014

See also
  Status Clinical Trial Phase
Completed NCT03961126 - Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma. Phase 2
Completed NCT03686800 - The Comfort and Adherence of Rivelin® Plain Patches in Vulva Lichen Sclerosus Patients N/A
Completed NCT05147129 - Characterizing the Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus
Completed NCT02573883 - Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus Phase 3
Recruiting NCT06132919 - Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) Phase 2
Completed NCT04952961 - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study N/A
Recruiting NCT04951206 - Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus Phase 4
Recruiting NCT05250466 - A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia N/A
Active, not recruiting NCT03926299 - Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus N/A
Completed NCT04148651 - The CO2RE® System for Vulvar Lichen Sclerosus N/A
Completed NCT02416531 - Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser N/A
Recruiting NCT04967170 - A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus Phase 1/Phase 2
Terminated NCT04134494 - Laser Treatment for Vulvar Lichen Sclerosus N/A
Completed NCT05251220 - Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women
Completed NCT01400022 - Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus N/A
Recruiting NCT06360705 - StrataMGT for the Treatment of Vulvar Lichen Sclerosus N/A
Completed NCT00757874 - Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus Phase 2
Recruiting NCT05243563 - Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone? Phase 2/Phase 3